CDC20 and urinary bladder cancer: To further evaluate the clinical correlation between Cdc20 and TPD52, we performed immunohistochemical (IHC) staining in bladder cancer patient samples and found a negative correlation (Rho = ‐0.1928, P = 0.0206) between the two proteins (Figure 6k,l).